December 05, 2016 10:37 AM ET

Pharmaceuticals

Company Overview of Aurinia Pharmaceuticals Inc. Prior To Merger With Isotechnika Pharma Inc.

Company Overview

As of September 23, 2013, Aurinia Pharmaceuticals Inc. was acquired by Isotechnika Pharma Inc. Aurinia Pharmaceuticals Inc. operates a clinical stage pharmaceutical company which focuses on the global nephrology market. The company holds the license for voclosporin in lupus nephritis. Aurinia Pharmaceuticals Inc. is based in Victoria, Canada.

4464 Markham Street

Suite 1203

Victoria, BC V8Z7X8

Canada

Phone:

250-744-2488

Fax:

250-744-2498

Key Executives for Aurinia Pharmaceuticals Inc. Prior To Merger With Isotechnika Pharma Inc.

Aurinia Pharmaceuticals Inc. Prior To Merger With Isotechnika Pharma Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
4everPets Ltd. Americas
9037136 Canada Inc. Americas
AAA Heidelberg Inc. Americas
Ab Biotech Inc. Americas
ABcann Medicinals Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aurinia Pharmaceuticals Inc. Prior To Merger With Isotechnika Pharma Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.